INTERIM REPORT 1 JANUARY - 31 MARCH 2013: SOLID BEGINNING OF THE YEAR DESPITE STRUCTURAL CHANGES OF BUSINESS OPERATIONS
Comunicato Precedente
Comunicato Successivo
OKMETIC OYJ STOCK EXCHANGE RELEASE 25 APRIL 2013 AT 8.00 A.M.
INTERIM REPORT 1 JANUARY - 31 MARCH 2013: SOLID BEGINNING OF THE YEAR DESPITE STRUCTURAL CHANGES OF BUSINESS OPERATIONS
Unless otherwise stated, figures in parenthesis refer to the corresponding period of the previous year.
JANUARY-MARCH IN BRIEF:
-
Net sales amounted to 16.4 (18.9) million euro, down 13.2%.
-
Silicon wafer shipments amounted to 15.5 (15.2) million euro, up 1.7%.
-
Operating profit was 1.4 (1.5) million euro corresponding to 8.4% of net sales.
-
Profit for the period was 1.2 (0.7) million euro.
-
Basic earnings per share was 0.07 (0.04) euro.
-
Net cash flow from operations amounted to 0.8 (-1.0) million euro.
PROJECTIONS FOR THE NEAR FUTURE
In 2013, the semiconductor industry's demand is estimated to take an upward turn again, and the sensor industry is forecast to continue on its growth track.
The demand for sensor wafers manufactured by Okmetic is estimated to be fairly stable throughout 2013. Due to normal seasonal fluctuation, the demand for semiconductor wafers will be slower in the beginning of the year and is likely to pick up in the second quarter.
Okmetic strives to outgrow the markets in its core business as a manufacturer of demanding silicon wafers in the current financial year as well. Technology sales, instead, have contracted significantly as a result of the solar cell industry's plummeted price level, which means structural change in the company's business. In 2013, the company's business will largely consist of silicon wafer sales. Nevertheless, the forecast growth of silicon wafer sales will not fully compensate for the steep decline in technology sales, which is why the company's net sales will decrease in 2013. Technology sales are reported under the title Other business as of 1 January 2013 due to their diminished weigh and varying content.
The company retains existing guidance, according to which net sales and operating profit for 2013 are estimated to remain under the level of 2012.
PRESIDENT KAI SEIKKU:
"In the first quarter, net sales decreased as anticipated due to considerable decline in technology sales. Demand for silicon wafers was low in the beginning of the year but, nevertheless, showed minor growth in relation to the comparison period. It was positive that the operating profit developed slightly better than the company expected. In addition, profit for the period, earnings per share, and net cash flow from operations strengthened clearly compared to the corresponding period last year. Net cash flow was improved by the reimbursement of income tax advances from 2012.
Reasonably good profitability was primarily based on successful cost management. Minor extraordinary items and exchange rate changes improved the result of the first quarter. By contrast, manufacturing of epitaxial wafers continued to be unprofitable at the Allen production plant.
Sensor wafer sales showed strong, over 10 percent growth in the beginning of the year. Due to good sales growth and decline in technology sales, the sensor wafers' share of net sales exceeded the level of 50 percent for the first time and amounted to as much as 60 percent. This development complies with Okmetic's long-term strategy. Despite the global macroeconomic challenges, demand outlook in the sensor industry is positive, since the amount of sensor applications continues to increase in many areas of life. Okmetic is a market leader and a forerunner as a supplier of demanding sensor wafers.
Demand for semiconductor wafers was low in the beginning of the year, as is seasonally typical. Asia's relative proportion of the company's entire net sales declined in the period under review. This was particularly due to the discontinuation of technology sales, or solar crystal shipments, that have been previously targeted to Asia, but also due to low demand in the Japanese market. The first quarter of the calendar year is typically the last in Japan, which is when the market usually slows down.
The silicon wafer market will partly pick up in the second quarter, and at the moment it seems that demand will be strongest in the third quarter. The lower-than-anticipated demand in the PC market and for certain consumer electronics devices create uncertainty of demand in the ongoing second quarter.
The company is currently in discussions to licence crystal growing expertise. Possible transactions will be communicated separately."
KEY FIGURES
|
1,000 euro |
1 Jan- |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
|
Net sales |
16,403 |
18,902 |
83,074 |
83,186 |
|
Operating |
|
|
|
|
|
Operating |
|
|
|
|
|
% of net sales |
8.4 |
8.1 |
9.7 |
14.2 |
|
Profit for |
|
|
|
|
|
Basic earnings |
|
|
|
|
|
Net cash flow |
|
|
|
|
|
Net interest- |
|
|
|
|
|
Equity ratio, % |
67.3 |
79.2 |
72.2 |
78.9 |
|
Average number |
|
|
|
|
MARKETS
Customer industries sensor and semiconductor industries
Sensor industry
According to different estimates, the sale value of sensor industry increased by approximately 6-10 percent in 2012 compared to the previous year. The development of sensor sales has been positively influenced by the increased use of micro sensors in many consumer electronics products. In 2013, the sale value of sensor industry is estimated to increase by 8-11 percent compared to 2012. In terms of volume, the sensor shipments are likely to clearly rise to a record level in 2013. For the next few years, the sale value of sensor industry is estimated to grow 8-13 percent annually. (IHS, Yole)
Semiconductor industry
In the last quarter of 2012, the semiconductor industry's sales in US dollars followed the seasonal fluctuation pattern typical of the industry. Even though the sales in the last quarter of 2012 grew from the previous year, the sales for the whole year were 2.7 percent below the level of the previous year (SIA). The markets are expected to recover from the second quarter of 2013 onwards and therefore, the growth estimates for the whole year settle between 4.0 and 5.6 percent (TSMC, WSTS, Gartner, iSuppli). The growth is expected to continue also in the following year.
Silicon wafer market
According to the report of SMG, the group of silicon wafer suppliers in SEMI (a global umbrella organisation for semiconductor materials and equipment industry), the surface area of silicon wafer shipments in 2012 calculated in square inches equaled the previous year's surface area as was estimated earlier. As a consequence of price erosion the silicon wafer market measured in US dollars decreased in 2012. The surface area is estimated to grow around 4.4 percent in 2013 (Gartner).
Okmetic's central customer areas in the silicon wafer market
In line with its strategy, Okmetic seeks for special areas of the entire silicon wafer market that have greater growth rates than the market average and in which the company has special expertise. Okmetic supplies primarily 150mm and 200mm wafers. The sensor/MEMS industry is Okmetic's central growth area. The MEMS market grows as portable consumer products, automotive electronics, and industrial process control increase.
In the semiconductor market, Okmetic's growth areas include discrete and power semiconductors. The growth areas of these markets are i.a. components used in the production of renewable energy, increasing automotive electronics, portable consumer products, as well as different solutions related to power supply and efficiency improvement.
CHANGE IN SALES REPORTING PER CUSTOMER AREA
Okmetic has changed its sales reporting per customer area as of the beginning of 2013. According to the new policy, technology sales are reported under the title Other business because of their diminished weigh and varying content.
SALES
In January-March, Okmetic's net sales were 16.4 (18.9) million euro. The net sales decreased by 13.2 percent (decrease of 14.3%) compared to the corresponding period last year mainly as a result of declining other business. Okmetic's market share remained stable in product areas important to the company, and the sales started to pick up towards the end of the first quarter as was anticipated.
Sales per customer area
|
|
1 Jan- |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
|
Sensors |
60% |
46% |
47% |
46% |
|
Semiconductors |
37% |
34% |
38% |
35% |
|
Other business |
3% |
20% |
15% |
19% |
The demand for sensor wafers continued strong and in January-March, the value of shipments was 10.5 percent higher than in the corresponding period last year. The demand for sensor wafers is estimated to continue solid throughout the year 2013.
The downturn of the semiconductor industry began to gradually change direction in the end of the first quarter, which improved semiconductor wafer sales. Because of low demand during January-February, the value of shipments in January-March was 10.1 percent lower than in the corresponding period last year.
During January-March, the value of shipments in other business was 0.5 million euro.
Sales per market area
|
|
1 Jan- |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
|
North America |
39% |
36% |
37% |
37% |
|
Europe |
36% |
26% |
27% |
30% |
|
Asia |
25% |
38% |
35% |
33% |
In the first quarter, Okmetic's sales were strongest in North America and Europe. Asia's relative proportion of net sales decreased in the period under review.
PROFITABILITY
January-March
In January-March, Okmetic's operating profit was 1.4 (1.5) million euro. The operating profit accounted for 8.4 (8.1) percent of net sales. Profit for the period was 1.2 (0.7) million euro. Basic earnings per share was 0.07 (0.04) euro. Diluted earnings per share was 0.07 (0.04) euro.
FINANCING
The company's financial position is good. In January-March, net cash flow from operations amounted to 0.8 (-1.0) million euro. Changes in working capital weakened the net cash flow by 2.6 (3.9) million euro. The reimbursement of income tax advances from 2012 improved the net cash flow of the period by 1.1 million euro.
On 31 March 2013, the company's interest-bearing liabilities amounted to 15.9 (1.0) million euro.
Okmetic announced in January that it has signed a five-year loan agreement for 10 million euro. The loan is used for the earlier announced investments and general corporate purposes.
At the end of the period, the cash and cash equivalents amounted to 13.9 (7.2) million euro. On 31 March 2013, the company's cash and cash equivalents were 2.0 million euro lower than the interest-bearing liabilities (on 31 March 2012, the cash and cash equivalents were 6.2 million euro higher than the interest-bearing liabilities). The company has ensured the sufficiency of cash funds by a credit facility of 6.0 million euro. On 31 March 2013, 3.0 million euro of the credit facility was in use (on 31 March 2012 the credit facility was undrawn).
Return on equity amounted to 7.8 (4.6) percent. The company's equity ratio was 67.3 (79.2) percent. Equity per share was 3.80 (3.69) euro.
INVESTMENTS
In January-March, Okmetic's capital expenditure amounted to 2.6 (2.6) million euro. The investments concerned debottlenecking and automatisation of wafer production lines.
PRODUCT DEVELOPMENT
In January-March, the company expensed 0.6 (0.5) million euro in product development projects. Product development costs accounted for 3.9 (2.8) percent of the net sales. The product development costs have not been capitalised. The product development has been allocated to SOI wafers as well as high and low resistivity wafers.
PERSONNEL
In January-March, Okmetic employed 358 (351) people on average. At the end of the period, Okmetic employed 354 (352) people of which 313 worked in Finland, 36 in the US, four in Japan, and one in Hong Kong.
BUSINESS RISKS
There have been no essential changes in the company's near future business risks and uncertainties.
Okmetic's silicon wafer sales are targeted at the sensor and semiconductor producers in the electronics industry. The demand for semiconductor wafers is sensitive to economic fluctuations and changes in the market situation can be sudden and dramatic. The demand for sensor wafers is more stable. The proliferation of sensors in consumer electronics applications may, however, increase the susceptibility of this market too to economic fluctuations. Technology sales have in recent years been mainly crystal sales to the solar cell industry. Okmetic has existing polysilicon purchasing obligations partly until 2015. As the price level of the solar cell market has dropped, the validity of long-term polysilicon contracts typical of the industry may cause a price risk.
Okmetic's share of the global silicon wafer market is around one percent and the market prices have a notable effect on the price development of Okmetic's products. The company only has considerable pricing power with its own special products. The pricing of other wafers is mainly based on global market price.
Okmetic operates globally, and therefore the company's business operations are affected by risks due to exchange rate fluctuations, consisting of the cash flows of purchases and sales. A significant part of sales are conducted in US dollars. Despite hedging, the company remains exposed to exchange rate fluctuations.
Substantial volumes of electricity are used in Okmetic's production. Despite hedging, the company is exposed to fluctuations in the price of electricity.
SHARES AND SHAREHOLDERS
On 31 March 2013, Okmetic Oyj's paid-up share capital, as entered in the Finnish Trade Register, was 11,821,250.00 euro. The number of shares was 17,287,500. The shares have no nominal value attached. Each share entitles its holder to one vote at general meetings. The company has one class of shares. The company's shares are included in the Finnish book-entry securities system.
|
Major shareholders on |
||
|
Shares, |
Share, |
|
|
Ilmarinen Mutual Pension |
|
|
|
Oy Ingman Finance Ab |
870,000 |
5.0 |
|
Mandatum Life Insurance |
|
|
|
The State Pension Fund |
600,000 |
3.5 |
|
Nordea Nordic Small |
|
|
|
Varma Mutual Pension |
|
|
|
Etra-Invest Oy Ab |
400,000 |
2.3 |
|
Okmetic Management Oy |
400,000 |
2.3 |
|
Okmetic Oyj |
227,946 |
1.3 |
|
Investment Fund |
|
|
|
Foreign investors and |
|
|
|
Other |
8,315,091 |
48.1 |
|
Total |
17,287,500 |
100.0 |
SHARE PRICE PERFORMANCE AND TRADING
A total of 1.0 (1.1) million shares were traded between 1 January and 31 March 2013, representing 5.8 (6.6) percent of the weighted average of share total of 17.3 (17.3) million during the period. The lowest quotation during the period was 4.33 (4.98) euro, and the highest 5.15 (6.01) euro, with the average being 4.71 (5.63) euro. The closing quotation for the period was 4.53 (5.82) euro. At the end of the period, the market capitalisation amounted to 78.3 (100.6) million euro.
DISCLOSURES OF HOLDINGS
On 12 March 2013 the total holdings that Oy Ingman Finance Ab (Trade Register number 2241895-0) had in the company rose to 5.03 percent.
OWN SHARES AND DIRECTED SHARE ISSUES
On 12 February 2013, Okmetic Oyj's board of directors announced of its decision to transfer a total of 18,540 own shares held by the company as a part of the company's share-based incentive scheme for the executive management group, of which the company has given a stock exchange release on 8 February 2012. All the shares were issued to the members of the executive management group in deviation from the shareholders' pre-emptive rights (directed share issue).
The rewards of the share reward programme were paid in Okmetic shares and in a monetary amount covering taxes. The directed share issue without payment was executed in full as there was no consideration related to the issue.
At the end of the reporting period Okmetic held 209,406 (241,543) own shares, which is approximately (1.2) 1.4 percent of Okmetic's all shares and votes.
More information relating to own shares and directed share issues can be found on the company website www.okmetic.com > Investors > Share information > Own shares.
OTHER EVENTS IN THE INTERIM PERIOD
Okmetic's board of directors decided on the share reward programme for the executive management group for 2013 as a part of the company's incentive and commitment plan in its meeting on 11 February 2013. The purpose of the programme is to commit and incentivise the executive management group to grow the shareholder value in the long run.
The programme's earning period is calendar year 2013. The possible rewards of the share reward programme will be paid in Okmetic shares and in a monetary amount covering the taxes in accordance with reaching the targets that have been set. The amount of the earned reward will be determined based on the realisation of the set targets and the possible reward will be paid to the persons in the programme after the financial statements for 2013 have been published. The amount of the rewards corresponds to a maximum of 150,000 shares.
EVENTS AFTER THE END OF THE INTERIM PERIOD
Annual general meeting on 10 April 2013
Okmetic Oyj's annual general meeting, which was held on 10 April 2013, adopted the annual accounts and the consolidated annual accounts for 2012 and discharged the company's management from liability. It was decided that a dividend of 0.25 euro per share would be distributed for 2012. The dividend was paid on Monday 22 April 2013. The annual general meeting decided also, in accordance with the proposal of the board of directors, to authorise the board of directors to decide upon its discretion on the payment of a dividend, should the company's financial situation permit this. The additional dividend, including all possible separate decisions on dividend payment, may amount up to a maximum of 0.40 euro per share and 15,000,000 euro in total. Moreover, the general meeting approved the proposal of the board of directors to authorise the board of directors to decide on the repurchase and/or the acceptance as pledge of the company's own shares as well as on the issuance of shares, the transfer of the company's own shares, and the issuance of special rights entitling to shares.
It was decided that there would be five members on the company's board of directors. Mr. Tapani Järvinen, Mr. Hannu Martola, Ms. Mervi Paulasto-Kröckel, Mr. Mikko Puolakka, and Mr. Henri Österlund were re-elected as members of the board of directors until the end of the next annual general meeting. The board of directors elected Henri Österlund as its chairman and Tapani Järvinen as its vice chairman in its organising meeting held immediately after the annual general meeting.
Authorised Public Accountant PricewaterhouseCoopers Oy was elected as auditor, with APA Mikko Nieminen having the principal responsibility.
Authorisations given to the board of directors and other decisions of the annual general meeting have been disclosed in a stock exchange release published on 10 April 2013.
CONDENSED FINANCIAL STATEMENTS AND TABLES 1 JANUARY - 31 MARCH 2013 (unaudited)
ACCOUNTING POLICIES
These interim financial statements have been prepared in accordance with IAS 34, Interim Financial Reporting.
In preparing these interim financial statements, Okmetic has followed the same accounting policies as in the financial statements for 2012 except for the effect of changes required by the adoption of certain new or revised standards and interpretations as of 1 January 2013, which have been described in financial statements 2012. The adoption of the new and revised standards and interpretations has not had an effect on the figures presented from the reporting period.
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
|
1,000 euro |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
Net sales |
16,403 |
18,902 |
83,074 |
|
Cost of sales |
-13,118 |
-14,851 |
-65,995 |
|
Gross profit |
3,285 |
4,051 |
17,079 |
|
Other income |
|
|
|
|
Operating |
|
|
|
|
Financial |
|
|
|
|
Profit before |
|
|
|
|
Income tax |
-58 |
-517 |
-2,510 |
|
Profit for |
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
Cash flow |
|
|
|
|
Translation |
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
Total |
|
|
|
|
|
|
|
|
|
Profit for the |
|
|
|
|
Equity holders |
|
|
|
|
|
|
|
|
|
Total |
|
|
|
|
Equity holders |
|
|
|
|
|
|
|
|
|
Basic earnings |
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
CONDENSED CONSOLIDATED BALANCE SHEET
|
1,000 euro |
31 Mar, |
31 Mar, |
31 Dec, |
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
Property, plant and |
|
|
|
|
Intangible assets |
739 |
83 |
636 |
|
Other receivables |
2,712 |
3,696 |
3,089 |
|
Total non-current |
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
Inventories |
15,760 |
14,963 |
13,526 |
|
Receivables |
16,371 |
16,933 |
17,796 |
|
Cash and cash |
|
|
|
|
Total current |
|
|
|
|
|
|
|
|
|
Total assets |
94,260 |
78,675 |
85,769 |
|
|
|
|
|
|
Equity and liabilities |
|
|
|
|
Equity |
|
|
|
|
Equity attributable |
|
|
|
|
Share capital |
11,821 |
11,821 |
11,821 |
|
Other equity |
51,605 |
49,914 |
50,038 |
|
Total equity |
63,426 |
61,735 |
61,860 |
|
|
|
|
|
|
Liabilities |
|
|
|
|
Non-current |
|
|
|
|
Current liabilities |
17,884 |
13,669 |
18,595 |
|
Total liabilities |
30,834 |
16,940 |
23,909 |
|
|
|
|
|
|
Total equity and |
|
|
|
CONDENSED CONSOLIDATED CASH FLOW STATEMENT
|
1,000 euro |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
Cash flows from operating |
|
|
|
|
Profit before tax |
1,277 |
1,229 |
7,600 |
|
Adjustments |
1,223 |
2,192 |
6,482 |
|
Change in working capital |
-2,626 |
-3,878 |
-1,124 |
|
Financial items |
-13 |
11 |
-47 |
|
Tax paid |
950 |
-520 |
-3,486 |
|
Net cash from |
|
|
|
|
|
|
|
|
|
Cash flows from investing |
|
|
|
|
Purchases of property, |
|
|
|
|
Net cash used in |
|
|
|
|
|
|
|
|
|
Cash flows from financing |
|
|
|
|
Proceeds from long- |
|
|
|
|
Proceeds from short- |
|
|
|
|
Payments of finance |
|
|
|
|
Other items |
- |
- |
10 |
|
Dividends paid |
- |
-201 |
-4,862 |
|
Net cash used in |
|
|
|
|
|
|
|
|
|
Increase (+) / |
|
|
|
|
Exchange rate changes |
-14 |
-313 |
-338 |
|
Cash and cash |
|
|
|
|
Cash and cash |
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
|
|
Equity attributable to equity holders of parent company |
|||||
|
|
Share |
Share |
Reserve |
Other |
Retained |
Total |
|
Balance at |
|
|
|
|
|
|
|
Profit for |
|
|
|
|
|
|
|
Other com- |
|
|
|
|
|
|
|
Cash flow |
|
|
|
|
|
|
|
Translation |
|
|
|
|
|
|
|
Total com- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based |
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
Profit for |
|
|
|
|
|
|
|
Other com- |
|
|
|
|
|
|
|
Cash flow |
|
|
|
|
|
|
|
Translation |
|
|
|
|
|
|
|
Total com- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
1)"Other reserves" contains hedge reserve and translation differences.
CHANGES IN PROPERTY, PLANT AND EQUIPMENT
|
1,000 euro |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
Carrying amount |
|
|
|
|
Additions |
2,569 |
2,592 |
14,342 |
|
Disposals |
- |
- |
- |
|
Depreciation |
1,302 |
1,512 |
-5,739 |
|
Exchange differences |
119 |
-120 |
-56 |
|
Carrying amount |
|
|
|
COMMITMENTS AND CONTINGENCIES
|
1,000 euro |
31 Mar, |
31 Mar, |
31 Dec, |
|
|
|
|
|
|
Loans, secured with |
|
|
|
|
Collaterals |
21,164 |
8,073 |
8,073 |
|
Off-balance sheet |
|
|
|
|
|
|
|
|
|
Capital commitments |
2,376 |
6,199 |
5,499 |
|
|
|
|
|
|
Nominal values of |
|
|
|
|
Currency options, |
|
|
|
|
Currency forward |
|
|
|
|
Electricity |
|
|
|
|
|
|
|
|
|
Fair values of |
|
|
|
|
Currency options, |
|
|
|
|
Currency forward |
|
|
|
|
Electricity |
|
|
|
The contract price of the derivatives has been used as the nominal value of the underlying asset.
HIERARCHY LEVELS OF DERIVATIVE CONTRACTS MEASURED AT FAIR VALUE
|
1,000 euro |
31 Mar, 2013 |
|
31 Dec, 2012 |
||||
|
Level |
Level |
Level |
|
Level |
Level |
Level |
|
|
Financial |
|
||||||
|
Derivative |
|
|
|
|
|
|
|
|
|
|||||||
|
Financial |
|
||||||
|
Derivative |
|
|
|
|
|
|
|
Fair value estimation
The group's financial instruments that are measured at fair value comprise derivatives used for hedging and held for trading, and they are classified on hierarchy level 2.
Fair values of level 2 instruments are based on other data than quoted prices in active markets, but on the data from which the asset is observable, either directly (i.e. price) or indirectly (i.e. derived from the prices).
Fair value determination
The fair values of currency derivatives are determined by using mark-to-market method at the reporting date.
The fair values of electricity derivatives are determined on the basis of market quotations and contract prices of the instruments at the reporting date.
KEY FIGURES SHOWING FINANCIAL PERFORMANCE
|
1,000 euro |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
Net sales |
16,403 |
18,902 |
83,074 |
|
Change in net sales |
|
|
|
|
Export and foreign |
|
|
|
|
Operating profit before |
|
|
|
|
% of net sales |
16.6 |
16.1 |
16.7 |
|
Operating profit |
1,373 |
1,535 |
8,018 |
|
% of net sales |
8.4 |
8.1 |
9.7 |
|
Profit before tax |
1,277 |
1,229 |
7,600 |
|
% of net sales |
7.8 |
6.5 |
9.1 |
|
Return on equity, % |
7.8 |
4.6 |
8.3 |
|
Return on investment, % |
6.6 |
7.9 |
11.8 |
|
Non-interest-bearing |
|
|
|
|
Net interest-bearing |
|
|
|
|
Net gearing ratio, % |
3.2 |
-9.8 |
-2.7 |
|
Equity ratio, % |
67.3 |
79.2 |
72.2 |
|
Capital expenditure |
2,569 |
2,592 |
14,342 |
|
% of net sales |
15.7 |
13.7 |
17.3 |
|
Depreciation |
1,352 |
1,517 |
5,846 |
|
Research and development |
|
|
|
|
% of net sales |
3.9 |
2.8 |
2.8 |
|
|
|
|
|
|
Average number of |
|
|
|
|
Personnel at the |
|
|
|
|
|
|
|
|
KEY FIGURES PER SHARE
|
Euro |
31 Mar, |
31 Mar, |
31 Dec, |
|
Basic earnings |
|
|
|
|
Diluted earnings |
|
|
|
|
Equity per share |
3.80 |
3.69 |
3.72 |
|
Dividend per share |
- |
- |
0.25 |
|
Dividends/earnings, % |
- |
- |
80.6 |
|
Effective dividend |
|
|
|
|
Price/earnings(P/E) |
- |
- |
16.2 |
|
|
|
|
|
|
Share performance |
|
|
|
|
Average trading price |
4.71 |
5.63 |
5.25 |
|
Lowest trading price |
4.33 |
4.98 |
4.21 |
|
Highest trading price |
5.15 |
6.01 |
6.01 |
|
Trading price at the |
|
|
|
|
Market capitalisation |
|
|
|
|
Trading volume (1 Jan-) |
|
|
|
|
Trading volume, |
|
|
|
|
In relation to weighted |
|
|
|
|
Trading volume, |
|
|
|
|
The weighted average |
|
|
|
|
The number of shares at |
|
|
|
QUARTERLY KEY FIGURES
|
1,000 euro |
10-12/ |
7-9/ |
4-6/ |
1-3/ |
|
|
|
|
|
|
|
Net sales |
|
|
|
16,403 |
|
Compared to previous |
|
|
|
|
|
Compared to corresponding |
|
|
|
|
|
Operating profit |
|
|
|
1,373 |
|
% of net sales |
|
|
|
8.4 |
|
Profit before tax |
|
|
|
1,277 |
|
% of net sales |
|
|
|
7.8 |
|
|
|
|
|
|
|
Net cash flow generated |
|
|
|
|
|
Investing activities |
|
|
|
-4,131 |
|
Financing activities |
|
|
|
9,904 |
|
Increase/decrease in cash |
|
|
|
|
|
|
|
|
|
|
|
Personnel at the end |
|
|
|
|
|
1,000 euro |
10-12/ |
7-9/ |
4-6/ |
1-3/ |
|
|
|
|
|
|
|
Net sales |
20,685 |
21,017 |
22,469 |
18,902 |
|
Compared to previous |
|
|
|
|
|
Compared to corresponding |
|
|
|
|
|
Operating profit |
1,007 |
2,970 |
2,506 |
1,535 |
|
% of net sales |
4.9 |
14.1 |
11.2 |
8.1 |
|
Profit before tax |
762 |
2,873 |
2,736 |
1,229 |
|
% of net sales |
3.7 |
13.7 |
12.2 |
6.5 |
|
|
|
|
|
|
|
Net cash flow generated |
|
|
|
|
|
Investing activities |
-2,650 |
-3,057 |
-2,652 |
-2,624 |
|
Financing activities |
-91 |
-288 |
-1,493 |
-201 |
|
Increase/decrease in cash |
|
|
|
|
|
|
|
|
|
|
|
Personnel at the end |
|
|
|
|
DEFINITIONS OF KEY FINANCIAL FIGURES
|
|
|
|
|
Operating profit before depreciation (EBITDA) |
= |
Operating profit + depreciation |
|
|
|
|
|
Return on equity (ROE), % |
= |
Profit/loss for the period x 100/ |
|
|
|
Equity(Average for the period) |
|
|
|
|
|
Return on investment (ROI), % |
= |
(Profit/loss before tax + interest and other financial expenses) x 100/ |
|
|
|
Balance sheet total - non-interest bearing liabilities(average for the period) |
|
|
|
|
|
Equity ratio, % |
= |
Equity x 100/ |
|
|
|
Balance sheet total - advances received |
|
|
|
|
|
Net interest-bearing liabilities |
= |
Interest-bearing liabilities - cash and cash equivalents |
|
|
|
|
|
Net gearing ratio, % |
= |
(Interest-bearing liabilities - cash and cash equivalents) x 100/ |
|
|
|
Equity |
|
|
|
|
|
Earnings per share |
= |
Profit/loss for the period attributable to equity holders of the parent company/ |
|
|
|
Adjusted weighted average number of shares in issue during the period |
|
|
|
|
|
Equity per share |
= |
Equity attributable to equity holders of the parent company/ |
|
|
|
Adjusted number of shares at the end of the period |
|
|
|
|
|
Dividend per share |
= |
Dividend for the period/ |
|
|
|
Adjusted number of shares at the end of the period |
|
|
|
|
|
Effective dividend yield, % |
= |
Dividend per share x 100/ |
|
|
|
Trading price at the end of the period |
|
|
|
|
|
Price/earnings ratio (P/E) |
= |
Last adjusted trading price at the end of the period/ |
|
|
|
Earnings per share |
|
|
|
|
|
Average trading price |
= |
Total traded amount in euro/ |
|
|
|
Adjusted number of shares traded during the period |
|
|
|
|
|
Market capitalisation at the end of the period |
= |
Number of shares at the end of the period x trading price at the end of the period |
|
|
|
|
|
Trading volume |
= |
Number of shares traded during the period/ |
|
|
|
Weighted average number of shares during the period |
All figures of the financial tables are rounded, and consequently the sum of individual figures can deviate from the presented sum figure.
The future estimates and forecasts in this interim report are based on the company management's current knowledge. Actual events and results may differ from the estimates presented here.
PRESS CONFERENCE
A press conference for the media and analysts will be held on Thursday, 25 April 2013 at 8.30 a.m. at the World Trade Center, Aleksanterinkatu 17, second floor, Helsinki. The result will be presented by President Kai Seikku. The press conference will be held in Finnish.
OKMETIC OYJ
Board of directors
For further information, please contact:
President Kai Seikku, Okmetic Oyj,
tel. +358 400 200 288, email: [email protected]
Senior Vice President, Finance, IT, and Communications
Juha Jaatinen, Okmetic Oyj, tel. +358 9 5028 0286,
email: [email protected]
Distribution:
NASDAQ OMX Helsinki
Principal media
www.okmetic.com
OKMETIC IN BRIEF
Take it higher
Okmetic is a technology company which supplies tailor-made silicon wafers for sensor and semiconductor industries and sells its technological expertise. Okmetic provides its customers with solutions that boost their competitiveness and profitability.
Okmetic's silicon wafers are part of a further processing chain that produces end products that improve human interaction and quality of life. Okmetic's products are based on high-tech expertise that generates added value for customers, innovative product development and an extremely efficient production process.
Okmetic has a global customer base and sales network, production plants in Finland and the US and contract manufacturers in Japan and China. Okmetic's shares are listed on NASDAQ OMX Helsinki under the code OKM1V. For more information on the company, please visit our website at www.okmetic.com.
Copyright Thomson Reuters
Attachment(s)
http://hugin.info/132025/R/1695946/558312.pdf
Regulatory News
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: %s via Thomson Reuters ONE
[HUG#1695946]
Ufficio Stampa
Thomson Reuters (Leggi tutti i comunicati)
3 Times Square
10036 New York, NY
